Bethkis Solution
Product Images NDC 10122-820

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Bethkis (NDC 10122-820). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chiesi Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tobramycin Structural Formula (Bethkis 1)

FDA Label Image

Mounting The Mouthpiece Onto The Nebulizer Cup Outlet (Bethkis 10)

FDA Label Image

Mounting The Inspiratory Valve Cap Onto The Nebulizer Cup Top (Bethkis 11)

FDA Label Image

Connecting The Tubing To The Compressor Air Outlet (Bethkis 12)

FDA Label Image

Plugging The Compressor Plug Into The Electrical Outlet (Bethkis 13)

FDA Label Image

Pushing The Tubing Onto The Air Intake Of The Nebulizer Cup (Bethkis 14)

FDA Label Image

Turning On The Compressor (Bethkis 15)

FDA Label Image

Checking A Steady Mist Coming From The Mouthpiece (Bethkis 16)

FDA Label Image

Placing The Mouthpiece In The Mouth (Bethkis 17)

FDA Label Image

14 Day (Bethkis 18)

FDA Label Image

Carton Label (Bethkis 19)

FDA Label Image

Figure 1 (Bethkis 2)

FDA Label Image

Bethkis Foil Pouch (Bethkis 20)

Bethkis & Chiesi's Tobramycin Inhalation Solution is a single-use solution that is intended for oral inhalation only by nebulizer. It is light-sensitive and should be stored in a refrigerator between 2°C to 8°C (36°F to 46°F). The solution does not contain preservatives and each ampule contains 4 mL of solution containing 300 mg of Tobramycin and 18 mg of sodium chloride in Water for Injection. The usual dose for the solution is provided in the package insert. It comes with four ampules in a foil pouch, and each ampule is meant for single use only, and should be discarded after use.*

FDA Label Image

Bethkis® (tobramycin Inhalation Solution) 300 mg / 4 mL Ampule Label (Bethkis 21)

Bethkis 300 mg/4mL is a tobramycin inhalation solution used for the treatment of lung infections such as cystic fibrosis.*

FDA Label Image

Bethkis Supplies (Bethkis 3)

FDA Label Image

Foil Pouch (Bethkis 4)

FDA Label Image

Separating Bethkis Ampule (Bethkis 5)

FDA Label Image

Opening Bethkis Ampule (Bethkis 6)

FDA Label Image

Opening The Nebulizer Cup (Bethkis 7)

FDA Label Image

Transferring Bethkis Medicine From The Ampule Into The Nebulizer Cup (Bethkis 8)

FDA Label Image

Closing The Nebulizer Cup (Bethkis 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.